Notice2026-11012
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 2, 2026
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Survey of Syringe Services Programs (NSSSP). This program was created to assess and monitor SSP operational characteristics and services, funding resources, community relations, and key operational and programmatic successes and challenges, and to support timely analysis and dissemination of national program evaluation survey findings.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 105 (Tuesday, June 2, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 105 (Tuesday, June 2, 2026)]
[Notices]
[Pages 32973-32974]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-11012]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-26-1359; Docket No. CDC-2026-0859]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled National Survey of Syringe Services Programs (NSSSP). This
program was created to assess and monitor SSP operational
characteristics and services, funding resources, community relations,
and key operational and programmatic successes and challenges, and to
support timely analysis and dissemination of national program
evaluation survey findings.
DATES: CDC must receive written comments on or before August 3, 2026.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2026-
0859 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road,
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#a4cbc9c6e4c7c0c78ac3cbd2"><span class="__cf_email__" data-cfemail="82edefe0c2e1e6e1ace5edf4">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including
[[Page 32974]]
whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
The National Survey of Syringe Services Programs (NSSSP) (OMB
Control No. 0920-1359, Exp. 1/31/2027)--Revision--National Center for
HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention, Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The primary purpose of the National Survey of Syringe Services
Programs (NSSSP) is to strengthen and improve the ability of CDC and
local and state partners to monitor and evaluate syringe services
programs (SSPs) nationally, with the overall goal of supporting,
sustaining, and improving SSPs nationwide and reducing infectious
disease and other harms related to drug use. Findings from the 2022-
2025 survey successfully characterized operational characteristics and
services, funding resources, community relations, and key operational
successes and challenges. The 2026 survey is currently being
implemented. Revisions are being requested to address the increasing
number of SSPs nationwide, updated infectious disease and substance use
prevention, testing, and treatment modalities, additional SSP services
provided, and additional information on overdose prevention and
reversals.
The project will include all SSPs that are listed in a publicly
available directory of all known SSPs in the United States maintained
by the North American Syringe Exchange Network (NASEN; <a href="https://nasen.org">https://nasen.org</a>). The project will also include SSPs in NASEN's directory
that do not wish to be publicly listed but have agreed to be contacted
for research purposes, SSPs belonging to NASEN's buyers' club that are
not part of the directory, respondents to prior RTI Arnold Ventures
Surveys of SSPs that are not part of NASEN's directory, and other SSPs
proactively identified through searching state health department
websites, funding agencies, state and regional networks, regional
conferences, partner organization networks or webinars and via social
media. SSPs will be sent a letter of invitation to participate in a 35-
minute program survey. Participating programs will have the option of
completing the survey via different modalities to enhance feasibility
and comfort in completing the survey, for example via the Research
Electronic Data Capture (REDCap) or a similarly secure web-based
application. Other modalities for survey administration will include a
coordinated telephone or videoconferencing interview. SSPs will be sent
reminder letters for an approximately 6-month data collection period.
The survey will include questions on operational characteristics
and services, funding resources, community relations, and key
operational successes and challenges. Approximately 1000 SSPs will be
able to participate in the survey. We anticipate that approximately 20%
of SSPs will decline to complete the survey, yielding approximately 800
completed surveys per year. However, given that it is challenging to
predict future response rates, we are requesting enough burden hours to
allow 100% of SSPs to respond to the survey. We estimate that it will
take 35 minutes to complete the survey, regardless of how the
respondent chooses to complete it (i.e., self-administered online or
interviewer-administered by phone or videoconferencing). SSPs that do
not respond to the initial survey invitation will be given reminders to
complete the survey over the duration of the survey implementation
period. CDC requests OMB approval for an estimated 583 annual burden
hours. There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total
Type of respondents Form name respondents responses per response burden (in
respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs............ National Survey of 1000 1 35/60 583
Syringe Services
Programs.
-----------------------------------------------------------------------------
Total......................... .................... ............ .............. ........... 583
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2026-11012 Filed 6-1-26; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 2, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.